[1] LI L,EMMETT N,MANN D,et al.Fenofibrate attenuates tubuloint erstitial fibrosis and inflammation through suppression of nuclear factor-KB and transforming growth factorβ1/Smad3 in diabetic nephropathy[J].Exp Biol Med(Maywood),2010,235(3):383.
[2] 魏群,顾乃刚,刘勇.左卡尼汀注射液对扩张型心肌病重度心力衰竭病人C反应蛋白的影响[J].中国老年学杂志,2011,31(24):4883.
[3] 张洪源,栾森,肖英.左卡尼汀对糖尿病肾病血液透析病人微炎症状态的改善作用观察[J].山东医药,2011,51(42):105.
[4] TURKMEN K,TONBUL HZ,ERDUR FM,et al.Peri-aortic fat tissue and malnutrition-inflammation-atherosclerosis/calcification syndrome in end-stage renal disease patients[J].Int Urol Nephrol,2013,45(3):857.
[5] 金尚福,林蔚素,黄德周,等.重组人促红细胞生成素对慢性肾功能衰竭维持性血液透析病人营养状态和红细胞免疫功能的影响[J].海峡药学,2009,21(4):114.
[6] 陈学波,胡玉纹,吴广宇.黄芪注射液联合重组人促红细胞生成素对血液透析病人红细胞免疫功能的影响[J].中国医师进修杂志,2010,33(22):24.
[7] 王靓,冯晓晨,高弼虎.血液透析病人红细胞免疫功能研究[J].中国综合临床,2012,28(9):942.
[8] CRUZ DN,DE CAL M,GARZOTTO F,et al.Effect of vitamin E-coated dialysis membranes on anemia in patients with chronic kidney disease:an Italian multicenter study[J].Int J Artif Organs,2008,31(6):545.
[9] MELHORN MI,BRODSKY AS,ESTANISLAU J,et al.CR1-mediated ATP release by human red blood cells promotes CR1 clustering and modulates the immune transfer process[J].J Biol Chem,2013,288(43):31139.
[10] 牛效清,梁东,刘中柱,等.慢性肾功能衰竭贫血病人红细胞免疫功能的改变[J].黑龙江医药科学,2010,33(1):9.
[11] YANG M,GAN H,SHEN Q,et al.Proinflammatory CD14+CD16+ monocytes are associated with microinflammation in patients with type 2 diabetes mellitus and diabetic nephropathy uremia[J].Inflammation,2012,35(1):388.
[12] 单剑萍,季刚.左卡尼汀对维持性血液透析病人微炎性反应状态相关炎性因子的影响[J].疑难病杂志,2012,11(7):514.
[13] 胡宏,余堂宏.左卡尼汀对慢性肾衰竭腹膜透析病人微炎症状态的影响[J].临床和实验医学杂志,2012,11(18):1488.
[14] 喻业安,夏瑗瑜,尹青桥,等.左卡尼汀对维持性血液透析病人微炎症状态及相关炎症因子的影响[J].医药导报,2011,30(1):55.
[15] 崔燕.左卡尼汀对促红细胞生成素治疗血液透析病人肾性贫血疗效的影响[J].中国基层医药,2011,18(24):3354.
[16] 夏季平,袁发焕,冯兵.左卡尼汀对血液透析病人红细胞变形性和膜稳定性的效应[J].重庆医学,2008,37(22):2594.
[17] 郝立志,刘栋梁.左卡尼汀在肾性贫血治疗中的应用及对氧化应激反应的影响[J].山东医药,51(52):112.